Şanlı, Fatma, et al. “The AKT Antagonist AZD5363 Suppresses Features Associated With Cancer Progression in Human Larynx Cancer Cells”. The European Research Journal, vol. 6, no. 5, Sept. 2020, pp. 380-7, https://doi.org/10.18621/eurj.624088.